Study Coordinator, PL
Boost your chances before you apply.
Champions Oncology Inc.
Las Vegas, NV, US
Summary
The Study Coordinator supports the Project Leadership team by managing study information, timelines, and database entries for oncology research projects. They also coordinate with internal operations groups to schedule study activities, manage protocol amendments, and facilitate sample logistics.
Job Description
Job Details: Level: Entry, Job Location: US Remote - Hackensack, NJ, Position Type: Full Time, Education Level: Bachelors Degree, Salary Range: Undisclosed, Travel Percentage: None, Job Shift: Monday - Friday, 9:00 AM - 5:00 PM, Job Category: Biotech, TITLE: Study Coordinator Translational Oncology Solutions (TOS)
REPORTING LOCATION: Rockville, MD / Remote, US
REPORTS TO: Manager of Project Leadership
SALARY RANGE: $50,000 -$65.000 yearly
PRIMARY OBJECTIVES
The Study Coordinator (SC) serves as the primary supporting role for the Project Leadership team who manages Champions vast portfolio of client sponsors regarding scientific design, PDX tumor model selection, and project execution. The SC will work closely with the Project Leaders/Study Directors and requires strong communication skills, attention to detail and the need to be highly organized. The SC will also interact and liaise with various internal operations groups at Champions to coordinate the scheduling/planning and execution of studies.
DUTIES AND RESPONSIBILITIES.
To support the Project Leadership team, duties and responsibilities will include:
Initial entry of study information into database(s) for project management purposes.
Assist in generating estimated study timelines.
Assist in planning/scheduling of studies in coordination with project leadership and operations teams.
Update study information as needed to capture protocol amendments.
Manage and update project timelines and milestones within database(s).
Work with operations for procurement of materials required for study execution.
Create initial study protocol drafts and amendments as appropriate.
Manage aspects of ongoing studies in the laboratory information management system in partnership with the Project Leader.
Perform and/or review enrollment of in vivo studies.
Assist in scheduling end of study activities/analyses with various operational groups.
Work with logistics to arrange shipment of samples to collaborators and clients/laboratories for studies.
Identifies and provides resolution to problems involving ongoing studies, as appropriate.
Participates and provides feedback in team meetings
Works independently and performs other related duties as assigned.
Qualifications: KNOWLEDGE, SKILLS AND ABILITIES
Knowledge of project management and oncology research. Knowledge of in vivo oncology models (Xenograft/PDX) preferred.
Ability to work in multiple databases to assist in project management.
Collaborative, can-do attitude. Timely decision making, good interpersonal skills and an ability to be persistent while maintaining tact.
Must have the ability to balance several priorities simultaneously with high attention to detail.
Ability for frequent adaptation, self-organization, accountability.
Effective oral and written communication skills are required.
Proficiency in using Microsoft Word and Excel.
EDUCATION AND EXPERIENCE
B.S. degree with appropriate experience or M.S. degree with a focus on a biology or chemistry related field, oncology a plus.
1 to 3 years of experience in the field of contract research, pre-clinical research or a similar position is preferred but not required.
PHYSICAL DEMANDS AND WORK ENVIRONMENT:
Must be able to sit for long periods of time using a computer in a typical office environment in a multi-level facility or home office.
This description reflects management’s assignment of essential functions, it does not proscribe or restrict the tasks that may be assigned. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.
From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.
Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.
Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
Founded
2007
Company size
201-500 employees
Industry
Biotechnology
Org type
Public Company
Headquarters
Hackensack, New Jersey
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.
From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.
Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.
Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
Founded
2007
Company size
201-500 employees
Industry
Biotechnology
Org type
Public Company
Headquarters
Hackensack, New Jersey